Sylvamo Corp <SLVM.N>: BofA Global Research cuts price objective to $45 from $58
SLVM•Related News
Electronics supplier Surge Components' Q2 EPS rises as margin improves
SPRS•
Wells Fargo tops profit estimates on interest income boost, trading boom
WFC•
Ionis partner Biogen plans Phase 3 development of tau-targeting Alzheimer’s drug diranersen after Phase 2 data
BIIB•
Allstate names Christian Lown CFO, effective Aug. 3
ALL•
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed
BIIB•